Theme: Current Challenges and Opportunities in Cost Effective and Affordable Biosimilars

Biosimilars-2014

Renowned Speakers

Biosimilars-2014

OMICS Group International contributes to the scientific community through its Open Access Initiative and OMICS Group Conferences. OMICS Group hosts over 400 leading-edge peer reviewed Open Access Journals which are supported by more than 30000 eminent Editorial Board Members through a 21 Days rapid, quality and quick review process. The enhanced feature of the websites includes the language translations into French, Chinese, and Spanish. OMICS Publishing Group journals have over 3.5 million readers and organize over 300 International Conferences annually all over the world with the support of more than 1000 scientific associations. OMICS Group Conferences conducts Scientific Conferences, symposia, workshops, trade shows, exhibitions and world congresses by bringing together people on a single platform thereby achieving and enlightening the knowledge across the world.

OMICS Group Conferences invites all the participants across the globe to attend the 3rd International Conference and Exhibition on Biowaivers, Biologics and Biosimilars during October 27-29, 2014 Hyderabad, India. The main theme of the conference is "Current Challenges and Opportunities in Cost Effective and Affordable Biosimilars" which covers a wide range of critically important sessions. Biowaivers, Biologics & Biosimilars International Conference 2014 is the best platform for Pharma, CMOs, CROs, research institutes, investors and industry stakeholders to meet, associate and discuss current industry trends and establish business partnerships. The target audience will be Vice Presidents, Directors, Heads of Departments in the field of Intellectual Property, Business Development, Bioequivalence, Regulatory/Legal Affairs, Research and Development and pharmacovigilance. Biowaivers, Biologics & Biosimilars International Conference 2014 will gather the experts in the biosimilar development, manufacturing and commercialization decision makers from all over the world. Biosimilars-2014 is collaborated with DPA (Doctor of Pharmacy Association), PAAi (Patent Agent Association), Association of Biotechnology and Pharmacy, Association of Pharmacy Professionals, BioFocus Research Center and Association of Pharmaceutical Teachers in India. Two Workshops are being organized by Dr. Shivraj Dasari, CSO of SLS Cell Culture Technologies Pvt. Ltd and Dr. Rajiv Dahiya, President, Association of Pharmacy Professionals at this esteemed scientific conference and this event will boost your industry knowledge and enhance relationships by networking between industrialists and academic leaders. Bio waivers & Biosimilars International Conference 2013 was supported by BioPort Folio (USA), ChemLinked (China) & Lab Bulletin (USA) and our Event exhibitor: FeF Chemicals, Denmark.   

Conference Highlights

  • Challenges and Regulatory Approach for Biosimilars
  • Emerging Biosimilars in Therapeutics
  • Clinical Studies and Clinicians Prospects for Biosimilars
  • Globalization of Biosimilars
  • Biosimilars Innovator Pharmaceutical Products
  • Analytical Strategies
  • Bioequivalence Assessment
  • BCS and IVIVC Based Biowaivers
  • Intellectual Property Rights
  • Pharmacovigilance and its Challenges
  • Plant Produced Biosimilar Products

To share your views and research, please click here to register for the Conference.

To Collaborate Scientific Professionals around the World

Conference Date October 27-29, 2014
Sponsors & Exhibitors Click here for Sponsorship Opportunities
Speaker Opportunity Closed Scientific Program
Poster Opportunity Closed Click Here to View